A glycoprotein that binds and inhibits myostatin — the body's primary genetic limiter on muscle growth. By removing the myostatin brake, Follistatin 344 allows muscle hypertrophy beyond normal physiological limits. Used in short burst cycles due to its potency and the body's compensatory mechanisms.
Myostatin is the body's built-in muscle growth limiter — a negative regulator that prevents excessive hypertrophy. Follistatin binds myostatin directly, neutralizing it. Without the brake, muscle tissue can grow beyond normal genetic ceilings.
Follistatin 344 is used in short burst cycles because the body upregulates myostatin production in response to follistatin. Extended use becomes less effective as compensatory mechanisms kick in.
The myostatin story began with the 'mighty mouse' — mice engineered without the myostatin gene showed dramatic increases in muscle mass (2-3x normal). This established myostatin as the primary genetic limiter of muscle growth.
Follistatin was identified as a natural myostatin antagonist. Gene therapy studies using follistatin showed significant muscle mass increases in animal models, and a Phase 1 gene therapy trial in humans with Becker muscular dystrophy demonstrated safety and preliminary efficacy.
Injectable follistatin 344 represents the peptide-based approach to myostatin inhibition. While less persistent than gene therapy, the burst protocol allows periodic myostatin suppression. Community use is limited to advanced users due to the compound's potency, cost, and limited human safety data.
| Compound | Mechanism | Approach | Cycle | Data Level |
|---|---|---|---|---|
| Follistatin 344 | Myostatin Binding | Burst protocol | 10–30 days | Limited human |
| IGF-1 LR3 | Growth Factor | Daily injection | 4–6 weeks | Moderate |
| MK-677 | GH Secretagogue | Oral daily | Continuous | Good |
| SARMs | Androgen Receptor | Daily oral | 8–12 weeks | Phase 2 level |
Follistatin 344's side effect profile is manageable with proper protocol adherence. Baseline blood work before starting and periodic monitoring during use is essential.
Follistatin 344 is the most direct approach to removing the myostatin brake on muscle growth. The 'mighty mouse' data is dramatic, and the human gene therapy trials showed it's biologically feasible. But this is an advanced compound with very limited human safety data, significant cost, and the need for precise burst-cycle timing (the body compensates by upregulating myostatin). Training intensity must be high during bursts — the compound is wasted without the growth stimulus. Stack with IGF-1 LR3 for maximum anabolic effect, and with BPC-157/TB-500 for the recovery support your connective tissue will need. Get comprehensive blood work including CK and FSH. Not for beginners.
Our free Protocol Guide includes the Performance Stack — Follistatin burst timing, IGF-1 LR3 pairing, and advanced blood work panels.